𝔖 Bobbio Scriptorium
✦   LIBER   ✦

EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib

✍ Scribed by Kobayashi, Susumu; Boggon, Titus J.; Dayaram, Tajhal; Jänne, Pasi A.; Kocher, Olivier; Meyerson, Matthew; Johnson, Bruce E.; Eck, Michael J.; Tenen, Daniel G.; Halmos, Balázs


Book ID
120386333
Publisher
Massachusetts Medical Society
Year
2005
Tongue
English
Weight
256 KB
Volume
352
Category
Article
ISSN
0096-6762

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Gefitinib or Chemotherapy for Non–Small-
✍ Maemondo, Makoto; Inoue, Akira; Kobayashi, Kunihiko; Sugawara, Shunichi; Oizumi, 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 341 KB

## Background: Non-small-cell lung cancer with sensitive mutations of the epidermal growth factor receptor (egfr) is highly responsive to egfr tyrosine kinase inhibitors such as gefitinib, but little is known about how its efficacy and safety profile compares with that of standard chemotherapy. ##